Navigation

Home > Resources > Training > Capacity Building Resources > Monitoring and Evaluation of HIV/AIDS Programs > Session 20: M&E for Treatment Programs > Patient Monitoring Resources > WHO HIV Drug Resistant Early Warning Indicators

WHO HIV Drug Resistant Early Warning Indicators

PDF document icon WHO HIV Drug Resistant Early Warning Indicators.pdf — PDF document, 2,160 kB (2,212,103 bytes)

Navigation

TB DIAH will run until September 2023, PMI Measure Malaria until June 2024, and D4I until September 2023.

MEASURE Evaluation is funded by USAID to strengthen capacity in developing countries to gather, interpret, and use data to improve health. We create tools and approaches for rigorous evaluations, providing evidence to address health challenges. And we strengthen health information systems so countries can make better decisions and sustain good health outcomes over time.

MEASURE Evaluation
Carolina Population Center
University of North Carolina at Chapel Hill
123 W Franklin St
Chapel Hill, North Carolina 27516
Email: measure@unc.edu
www.measureevaluation.org

MEASURE Evaluation is funded by the United States Agency for International Development (USAID) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). The information provided on this web site is not official U.S. government information and does not necessarily represent the views of USAID, PEPFAR or the U.S. government.

WHO HIV Drug Resistant Early Warning Indicators

Personal tools